الفهرس 
Diabetes MellitusOnly 14 pages are availabe for public view
 |  | from | 90 |  |  |
| | | from | 90 | | |
Abstract
The global prevalence of diabetes mellitus (DM) continues to rise at an alarming rate. It is acknowledged as a principal risk factor for cardiovascular morbidity and mortality and has a heavy impact on the global health expenditure due to both its short and long term complications , The complications of type 2 diabetes are common and largely account for the excess morbidity and mortality associated with this disease. As such routine screening of asymptomatic patients with diabetes for retinopathy, nephropathy and neuropathy is recommended . Diabetes is a major risk factor for coronary heart disease and cardiovascular disease is the most important cause of morbidity and mortality in patients with diabetes, accounting for approximately two-thirds of total mortality . Diabetes mellitus is associated with a cardiomyopathy characterized by left ventricular hypertrophy (LVH) and diastolic dysfunction. LVH in patients with DM has been widely implicated and therefore considered as a treatment target, aiming to reduce cardiovascular risk. Insulin resistance and associated abnormal glucose metabolism have been implicated in many reports as a possible pathophysiological mechanism of LVH. This therefore highlights the need for the early detection of LVH in DM in order to institute a timely effective control with subsequent improvement in prognosis . Echocardiography provides a reliable noninvasive estimation of LV mass and has been proven to be a more sensitive tool for the detection of LVH than electrocardiogram (ECG) .
LV mass in diabetic patients increases with the duration of diabetes, and also increases with the glycosylated hemoglobin(HbA1c) level.So a poor glycemic control is also associated with more chances of having LVH